-
1.发明公开
公开(公告)号：EP1098634A2
公开(公告)日：2001-05-16
申请号：EP99935300.6
申请日：1999-07-20
IPC分类号： A61K9/14
CPC分类号： A61K31/44 , A61K9/146 , A61K9/1623 , A61K9/1635 , A61K9/2077 , A61K31/415 , A61K31/4178 , A61K31/54 , A61K31/635 , A61K2300/00
摘要： This invention relates to bioenhanced formulations comprising eprosartan or eprosartan mesylate in the amorphous form, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
-
2.发明授权EPROSARTAN ARGINYL CHARGE-NEUTRALIZATION-COMPLEX AND A PROCESS FOR ITS PRODUCTION AND FORMULATION 有权普沙坦精氨电荷中和复杂AND METHOD FOR ITS和管理
公开(公告)号：EP1027047B1
公开(公告)日：2006-10-04
申请号：EP98939213.9
申请日：1998-08-04
IPC分类号： A61K31/415 , C07D233/02 , C07D233/04 , C07D409/06
CPC分类号： C07D409/06
摘要： This invention relates to (E)-α-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene-2-thiophenepropionic acid arginyl charge-neutralization-complex, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
-
3.发明公开EPROSARTAN ARGINYL CHARGE-NEUTRALIZATION-COMPLEX AND A PROCESS FOR ITS PRODUCTION AND FORMULATION 有权普沙坦精氨电荷中和复杂AND METHOD FOR ITS和管理
公开(公告)号：EP1027047A1
公开(公告)日：2000-08-16
申请号：EP98939213.9
申请日：1998-08-04
IPC分类号： A61K31/415 , C07D233/02 , C07D233/04
CPC分类号： C07D409/06
摘要： This invention relates to (E)-α-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene-2-thiophenepropionic acid arginyl charge-neutralization-complex, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
-
-
搜索结果
3 条记录 (耗时 0.011 秒)
